US Physical Therapy
USPH
Market cap $1.17B

77.00 USD

-1.14

1.46%

At close Jun 13, 4:00 PM EDT

After hours

77.00

+0.00

0.00%

1 day

-1.46%

5 days

-1.71%

1 month

-0.27%

3 months

0.06%

6 months

-17.61%

Year to date

-12.38%

1 year

-18.69%

5 years

2.11%

10 years

52.69%

About: US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Employees: 7,028

Healthcare Medical Care Facilities

0

Funds holding %

of 7,296 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

56% more call options, than puts

Call options by funds: $123K | Put options by funds: $79K

12% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 25

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]

1% less funds holding

Funds holding: 255 [Q4 2024] → 252 (-3) [Q1 2025]

2.5% less ownership

Funds ownership: 103.08% [Q4 2024] → 100.58% (-2.5%) [Q1 2025]

20% less capital invested

Capital invested by funds: $1.38B [Q4 2024] → $1.11B (-$275M) [Q1 2025]

26% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 111

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$110

43%

upside

Avg. target

$112

45%

upside

High target

$113

47%

upside

2 analyst ratings

2 positive

100%

0 neutral

0%

0 negative

0%

JMP Securities Constantine Davides	47%upside $113	Market Outperform Reiterated	22 Apr 2025
JP Morgan Calvin Sternick	43%upside $110	Overweight Maintained	19 Mar 2025

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about USPH published over the past 30 days

U.S. Physical Therapy Presented at Investor Conferences

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, presented at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, and Carey Hendrickson, Chief Financial Officer, presented at the 15th Annual East Coast IDEAS Conference on June 11, 2025. The presentations provided an overview of t.

U.S. Physical Therapy Presented at Investor Conferences

Zacks Investment Research

ELAN vs. USPH: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Elanco Animal Health Incorporated (ELAN) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?

ELAN vs. USPH: Which Stock Should Value Investors Buy Now?

U.S. Physical Therapy Announces Dual Listing on NYSE Texas

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same “USPH” ticker.

U.S. Physical Therapy Announces Dual Listing on NYSE Texas

Zacks Investment Research

Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock?

Investors need to pay close attention to USPH stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock?

U.S. Physical Therapy, Inc. (USPH) Q1 2025 Earnings Call Transcript

U.S. Physical Therapy, Inc. (NYSE:USPH ) Q1 2025 Earnings Conference Call May 8, 2025 10:30 AM ET Company Participants Christopher Reading - Chairman and Chief Executive Officer Jason Curtis - Senior Vice President of Finance and Accounting Carey Hendrickson - Chief Financial Officer Eric Williams - President and Chief Operating Officer Conference Call Participants Joanna Gajuk - Bank of America Benjamin Rossi - JPMorgan Chase & Co. Brian Tanquilut - Jefferies Lawrence Solow - CJS Securities, Inc. Jared Haase - William Blair & Company Constantine Davides - Citizens JMP Securities Michael Petusky - Barrington Research Associates, Inc. Operator Good day, everyone, and thank you for standing by. Welcome to the U.S. Physical Therapy First Quarter 2025 Conference Call.

U.S. Physical Therapy, Inc. (USPH) Q1 2025 Earnings Call Transcript

Zacks Investment Research

U.S. Physical Therapy (USPH) Beats Q1 Earnings Estimates (Revised)

U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.51 per share a year ago.

U.S. Physical Therapy (USPH) Beats Q1 Earnings Estimates (Revised)

Zacks Investment Research

U.S. Physical Therapy (USPH) Lags Q1 Earnings Estimates

U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.51 per share a year ago.

U.S. Physical Therapy (USPH) Lags Q1 Earnings Estimates

U.S. Physical Therapy Reports First Quarter 2025 Results

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the first quarter ended March 31, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $19.5 million for the three months ended March 31, 2025 (“2025 First Quarter”), an increase of $2.8 million, or 1.

U.S. Physical Therapy Reports First Quarter 2025 Results

U.S. Physical Therapy Clinics Market Analysis 2025: $53 Billion Industry Primed for Consolidation - M&A Activity Surges in Fragmented Therapy Sector

Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "U.S. Physical Therapy Clinics: An Industry Analysis" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.

U.S. Physical Therapy Clinics Market Analysis 2025: $53 Billion Industry Primed for Consolidation - M&A Activity Surges in Fragmented Therapy Sector

U.S. Physical Therapy Announces the Acquisition of an Outpatient Home Care Physical and Speech Therapy Practice

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (the Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of an outpatient home care practice that provides physical, occupational, and speech therapy through its 50%-owned subsidiary, MSO Metro, LLC (“Metro”). The practice currently generates approximately $2.1 million in annual revenues. Metro acquired an 80% interest in the acqui.

U.S. Physical Therapy Announces the Acquisition of an Outpatient Home Care Physical and Speech Therapy Practice

See News Rankings

Charts implemented using Lightweight Charts™